News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


Rare disorders process yields first funding decision

Rare disorders process yields first funding decision

People with the rare blood condition hereditary angioedema are the first to benefit from the increased competition for rare disorders medicines promoted by PHARMAC.

PHARMAC has approved an agreement with Shire Pharmaceuticals to fund icatibant (Firazyr), which treats hereditary angioedema (HAE). HAE causes episodic attacks of swelling that can be life-threatening.

Chief Executive Steffan Crausaz says PHARMAC began testing a new approach to promote competition in 2014, seeking better access to medicines for people with rare disorders. PHARMAC identified up to $25 million available over five years, and sought proposals from companies supplying medicines for rare disorders.

“We received proposals for 28 medicines, many of them previously not seen in NZ before and from suppliers PHARMAC has not previously done business with. Shire, for example, had not previously supplied medicines in NZ.”

“We’re intending this to be the first of several medicines that will be affordable within the $25 million we have identified as available for rare disorders medicines,” says Steffan Crausaz.

“This is a great outcome for people with hereditary angioedema, and we’re confident of more agreements being reached for other rare disorders in the near future.”

Icatibant can be used to treat severe attacks of hereditary angioedema. An injection that people can have at home, its use can avoid the need for people to go to hospital for infusion treatment. Because it avoids the need for people to visit hospital for in-hospital treatment, PHARMAC estimates the funding decision should save DHBs money.

PHARMAC estimates there may be up to 90 patients with hereditary angioedema in New Zealand, of whom up to 25 may meet the criteria for funded treatment with icatibant.


© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


Howard Davis: And The Oscar Goes To … Parasite
For its deliciously dark wit and genre-bending ingenuity, Bong Joon-ho's latest movie has just won four out of a potential six Academy Awards, including Best Screenplay and Director. Only ten foreign-language films have previously been nominated for Best Picture and none have won before. More>>

Howard Davis: 1917's 1,000 Yard Stare

Sam Mendes has created a terrible and barbarous trek, one that we appreciate all the more for being catapulted right into the midst of this ear-splitting melee from the film's opening sequence. More>>

Floorball: NZ To Host World Cup Of Floorball In 2022

In a major coup for a minnow nation in the European-dominated sport of floorball, New Zealand has won the rights to host one of the sport’s marque international events. More>>

National Voyage Continues: Tuia 250 Ends

Tuia 250 has unleashed an unstoppable desire to keep moving forward and continue the kōrero about who we are, say the co-chairs of the Tuia 250 National Coordinating Committee, Dame Jenny Shipley and Hoturoa Barclay-Kerr. More>>


Over 150 Productions: NZ Fringe 2020 Has Launched

The upcoming festival will be held at 40 venues all over Wellington Region from 28 February to 21 March, and includes every genre possible—theatre, comedy, dance, music, clowning, cabaret, visual art, children’s shows and more! More>>





  • Wellington
  • Christchurch
  • Auckland